These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26195816)

  • 1. The high-resolution crystal structure of human LCAT.
    Piper DE; Romanow WG; Gunawardane RN; Fordstrom P; Masterman S; Pan O; Thibault ST; Zhang R; Meininger D; Schwarz M; Wang Z; King C; Zhou M; Walker NP
    J Lipid Res; 2015 Sep; 56(9):1711-9. PubMed ID: 26195816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
    Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.
    Glukhova A; Hinkovska-Galcheva V; Kelly R; Abe A; Shayman JA; Tesmer JJ
    Nat Commun; 2015 Mar; 6():6250. PubMed ID: 25727495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.
    Manthei KA; Ahn J; Glukhova A; Yuan W; Larkin C; Manett TD; Chang L; Shayman JA; Axley MJ; Schwendeman A; Tesmer JJG
    J Biol Chem; 2017 Dec; 292(49):20313-20327. PubMed ID: 29030428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BacMam production of active recombinant lecithin-cholesterol acyltransferase: Expression, purification and characterization.
    Romanow WG; Piper DE; Fordstrom P; Thibault S; Zhou M; Walker NP
    Protein Expr Purif; 2016 Sep; 125():1-6. PubMed ID: 26363122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency.
    Yang XP; Inazu A; Honjo A; Koizumi I; Kajinami K; Koizumi J; Marcovina SM; Albers JJ; Mabuchi H
    J Lipid Res; 1997 Mar; 38(3):585-91. PubMed ID: 9101439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
    Kunnen S; Van Eck M
    J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.
    Gorshkova IN; Mei X; Atkinson D
    J Lipid Res; 2018 Feb; 59(2):348-356. PubMed ID: 29208698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
    O K; Hill JS; Pritchard PH
    Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lecithin cholesterol acyltransferase.
    Jonas A
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):245-56. PubMed ID: 11111093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease.
    Vanloo B; Peelman F; Deschuymere K; Taveirne J; Verhee A; Gouyette C; Labeur C; Vandekerckhove J; Tavernier J; Rosseneu M
    J Lipid Res; 2000 May; 41(5):752-61. PubMed ID: 10787436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the 121-136 domain of lecithin:cholesterol acyltransferase using antibodies.
    Murray KR; Nair MP; Ayyobi AF; Hill JS; Pritchard PH; Lacko AG
    Arch Biochem Biophys; 2001 Jan; 385(2):267-75. PubMed ID: 11368007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line.
    Lane SB; Tchedre KT; Nair MP; Thigpen AE; Lacko AG
    Protein Expr Purif; 2004 Aug; 36(2):157-64. PubMed ID: 15249036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity.
    Peelman F; Verschelde JL; Vanloo B; Ampe C; Labeur C; Tavernier J; Vandekerckhove J; Rosseneu M
    J Lipid Res; 1999 Jan; 40(1):59-69. PubMed ID: 9869650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.
    Holleboom AG; Kuivenhoven JA; Peelman F; Schimmel AW; Peter J; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Motazacker MM
    Hum Mutat; 2011 Nov; 32(11):1290-8. PubMed ID: 21901787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.